Role of transurethral resection of the prostate in the diagnosis of prostate cancer for patients with lower urinary tract symptoms and serum PSA 4-10ng/ml with a negative repeat transrectal needle biopsy of prostate

Korean Journal of Urology

Volumn 48, Issue 10, 2007, Pages 1010-1015

  Cho, Kang Jun ^a   Ha, U Syn ^a   Lee, Choong Bum ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Needle biopsy; Prostate cancer; Transurethral resection of prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; TRANSURETHRAL RESECTION;

EID: 35848943675     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2007.48.10.1010     Document Type: Article

References (30)

1. Terris MK. Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary report. Urology 1999;54:486-9
2. Bazinet M, Karakiewicz PI, Aprikian AG, Trudel C, Aronson S, Nachabe M, et al. Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol 1996; 155:605-6
3. Terris MK, Pham TQ, Issa MM, Kabalin JN. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol 1997;157:204-6
4. Fleshner NE, Fair WR. Indications for transition zone biopsy in the detection of prostatic carcinoma. J Urol 1997;157:556-8
5. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-4
6. Terris MK, Wallen EM, Stamey TA. Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer. Urol Int 1997;59:239-42
7. Moon KH, Cheon SH, Kim CS. Systematic 10-site prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. Korean J Urol 2000;41:1178-82
8. Yeo BG, Lee ES, Byun SS. Peripheral 10 sites prostate biopsy: Is it really effective? Korean J Urol 2003;44:851-4
9. Durkan GC, Sheikh N, Johnson P, Hildreth AJ, Greene DR. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol. BJU Int 2002;89:33-9
10. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 2000; 164:388-92
11. Djavan B, Ravery V, Zlotta A, Dobronski P, Dobrovits M, Fakhari M, et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 2001;166:1679-83
12. Keetch DW, McMurtry JM, Smith DS, Andriole GL, Catalona WJ. Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J Urol 1996;156:428-31
13. Roehl KA, Anterior JA, Catalona WJ. Serial biopsy results in prostate cancer screening study. J Urol 2002;167:2435-9
14. Merrill RM, Wiggins CI. Incidental detection of population based prostate cancer incidence rates through transurethral resection of the prostate. Urol Oncol 2002;7:213-9
15. Zigeuner R, Schips L, Lipsky K, Auprich M, Salfellner M, Rehak P, et al. Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies. Urology 2003;62:883-7
16. Lee SC, Lee SC, Kim WJ. Value of PSA density, PSA velocity and percent free PSA for detection of prostate cancer in patients with serum PSA 4-10ng/ml patients. Korean J Urol 2004;45:747-52
17. Kitamura H, Masumori N, Tanuma Y, Yanase M, Itoh N, Takahashi A, et al. Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant and transition zone biopsies? Int J Urol 2002;9:95-9
18. Onder AU, Yalcin V, Arar O, Yaycioglu O, Citci A, Solok V. Impact of transition zone biopsies in detection and evaluation of prostate cancer. Eur Urol 1998;33:542-8
19. Reissigl A, Pointner J, Strasser H, Ennemoser O, Klocker H, Bartsch G. Frequency and clinical significance of transition zone cancer in prostate cancer screening. Prostate 1997;30: 130-5
20. Keetch DW, Catalona WJ. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. J Urol 1995;154: 1795-7
21. Pelzer AE, Bektic J, Berger AP, Halpern EJ, Koppelstatter F, Klauser A, et al. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project. Eur Urol 2005;48:916-21
22. Ornstein DK, Rao GS, Smith DS, Andriole GL. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate. J Urol 1997;157: 880-3
23. Ito H, Yamaguchi K, Kotake T, Matsuzaki O, Nagao K. Usefulness of aspiration cytology in prostate cancer detection. Int Urol Nephrol 1995;27:93-100
24. Niesel T, Breul J, Hartung R. Diagnostic value of additional systematic prostate biopsies in patients undergoing transurethral resection of the prostate. Urology 1997;49:869-73
25. Rovner ES, Schanne FJ, Malkowicz SB, Wein AJ. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies. J Urol 1997;158:138-41
26. Puppo P, Introini C, Calvi P, Naselli A. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer. Eur Urol 2006;49:873-8
27. Colombo R, Naspro R, Salonia A, Montorsi F, Raber M, Suardi N, et al. Radical prostatectomy after previous prostate surgery: clinical and functional outcomes. J Urol 2006;176: 2459-63
28. Djavan B, Mazal P, Zlotta A, Wammack R, Ravery V, Remzi M, et al. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Prostate 2001;47: 111-7
29. Ryu SH, Chai SE, Choi HY. Predictive factors of prostatic cancer detection on repeat prostate biopsy. Korean J Urol 2003;44:1-5
30. Durkan GC, Greene DR. Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: Who should undergo a repeat biopsy? BJU Int 1999;83:34-8